ALA 4.62% 15.5¢ arovella therapeutics limited

Road to nowhere, page-114

  1. 3,958 Posts.
    lightbulb Created with Sketch. 492
    IMO some of the comments on here about a sale of Westcoast plus the mention in the article yesterday gives me the impression that it is going to be sold soon and the company is priming shareholders for this news.

    Is it a good thing?

    Well you could argue either way

    In the negative camp:
    Selling the only source of recurring revenue especially after the business has been turned around seems downright foolish. If its turning profitable why not keep it and have it continue to add to the bottom line?

    In the positive camp:
    Surely they wouldnt be selling their only source of recurring revenue if they didnt have a strong feeling of anticipated cash inflows?
    Selling Westcoast should give the company cash to avoid/delay a CR (of course this clearly is a function of the sale price)


    All shall be revealed in the fullness of time but I think when you see an article like yesterdays, and yes Tim Boreham has written about SUDA in the past, and when this comes out NOT on the back of an announcement, it indicates to me that a message is trying to be delivered.

    Lets see what happens and lets see how the market reacts.

    Good luck all
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.